Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion
Status:
Unknown status
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of the treat-and-extend
regimen extending to 4 months by intervals of 4 weeks using intravitreal aflivercept
injection for treatment of macular edema secondary to BRVO.